Radiofrequency-assisted Transection of the Pancreas vs Stapler — TRANSPAIRE  

Pancreas; Fistula Clinical Trial

Official title: Radiofrequency-assisted Transection of the Pancreas vs Stapler. A Phase III Randomized Clinical Trial.

Status Recruiting

Clinical Trial Summary

Main objective: The main end-point of this study is to compare in a randomized clinical trial that radiofrequency-assisted pancreas transection (RF) reduces the incidence of postoperative pancreatic fistula (POPF) compared to the classical method of transection (stapler). As secondary end-points, other clinical and demographic variables of the patients will be evaluated (sex, age, ASA classification, consistency of the pancreas, as well as the type of procedure, open or laparoscopic surgery, estimated intraoperative bleeding, pancreatic duct size, duration of intervention, type of tumor and quality of lymphatic resection). Methodology: Phase III prospective multicenter study in patients undergoing distal pancreatectomy for any origin. All consecutive patients who undergo a distal pancreatectomy for any cause in a multicenter setting will be included. A simple randomization of the participants to the RFA group or to the control group (stapler) will be carried out. The incidence of pancreatic fistula will be assessed as main variable; predictive multivariable models with multiple regression for quantitative variables, logistic regression for categorical variables and Cox regression for survival analyzes. In addition to histological study, molecular analysis of resection specimen and clinical and radiological follow-up with volumetry of necrosis in the area of post-pancreatectomy transection will be performed.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Fistula
• Pancreas; Fistula
• Pancreatic Fistula

• NCT number: NCT04402346
• Study type: Interventional
• Source: Hospital del Mar
• Contact: Patricia Sánchez-Velázquez, MD PhD FEBS
• Phone: +34 932483207
• Email: Psanchezvelazquez@psmar.cat
• Status: Recruiting
• Phase: N/A
• Start date: February 15, 2021
• Completion date: December 31, 2023